Christopher Wiltshire
Vorstandsvorsitzender bei Hematherix LLC
Profil
Christopher Wiltshire is the founder of Hematherix LLC (founded in 2015),.
Ipt Bioconsulting LLC (founded in 2008), and Hemastasyx Ltd.
(founded in 2015) where he holds the title of Chief Executive Officer.
He previously worked as the Head of Business Transactions & Investments at The Pfizer Incubator LLC from 1998 to 2008.
From 2018 to 2022, he worked as the Executive Director & Chief Business Officer at Ovoca Bio Plc.
He also worked as the Head of Business Development & Licensing at La Jolla Pharmaceutical Co. Mr. Wiltshire graduated from the University of Cambridge and holds an MBA from the University of Virginia Darden School of Business.
Aktive Positionen von Christopher Wiltshire
| Unternehmen | Position | Beginn |
|---|---|---|
| Hematherix LLC | Vorstandsvorsitzender | 01.01.2015 |
| Hemastasyx Ltd. | Vorstandsvorsitzender | 01.01.2015 |
Ehemalige bekannte Positionen von Christopher Wiltshire
| Unternehmen | Position | Ende |
|---|---|---|
| OVOCA BIO PLC | Direktor/Vorstandsmitglied | 31.01.2022 |
| Ipt Bioconsulting LLC | Gründer | 01.01.2015 |
| The Pfizer Incubator LLC | Corporate Officer/Principal | 01.01.2008 |
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - |
Ausbildung von Christopher Wiltshire
| University of Cambridge | Graduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OVOCA BIO PLC | Health Technology |
| Private Unternehmen | 5 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
| The Pfizer Incubator LLC | |
| Hematherix LLC | |
| Ipt Bioconsulting LLC | |
| Hemastasyx Ltd. |
